Skip to main content




Leeftijd icoon
50 - 85 years
Diagnose icoon
Mild to moderate Alzheimer's disease
Duratie onderzoek
9 weeks
Locatie icoon

About this research

In order to participate in this study, you must be able to speak and read Dutch fluently.

The goal of this study is to evaluate how safe and effective the new drug REM0046127 is for the treatment of participants with mild to moderate Alzheimer’s disease. The study compares the effect of the new drug REM0046127 with the effect of a placebo (a drug without an active ingredient, a ‘fake drug’). The study drug is administered orally.

Alzheimer’s disease leads to a loss of nerve cells and impairs the function of the brain. It can also lead to behavioral abnormalities and a decreasing ability to perform basic activities of daily living. REM0046127 potentially targets different aspects of Alzheimer’s, such as improving the strength of nerve cell connections and cognition, and reducing amyloid beta plaques and neuroinflammation, all of which are strongly associated with Alzheimer’s. The aim of this study is thus to observe if and how the medication works and if it can stop the decay of the nerve cells.

You and your study partner, someone who knows you well and can answer questions about your daily functioning, will visit the research center approximately 7 times, during approximately 9 weeks. In addition, you will also have a check-up via telephone. The duration of a visit is not always the same because not every visit has the same procedures. Some of these visits may last 6 hours, others 3.5 hours or shorter. A phone call takes around 15 minutes. The research takes place in Amsterdam.

Your study partner should also help to administer the medication twice a day during the treatment period.

This study is commissioned by reMYND NV.

This text has been directly translated from the Dutch trial description as approved by the Ethical Committee.

How does the application process go?

You always decide whether you participate in a study. Participation is always voluntary.

  1. You apply via the online form, this is non-binding.
  2. After application, you are phoned, this is also an opportunity for you to ask questions. During this conversation, we also ask some questions to see whether you are eligible to participate in research. After this conversation, you determine whether you want to progress to step 3.
  3. You receive an email with the request to sign a document in which you give permission to retrieve your medical data.
  4. When your medical data shows that you meet the requirements to participate in the study, you are invited to a meeting at our location. During this meeting, you receive information and have the opportunity to ask questions, before you decide to participate in research.
  5. If you decide to participate in the study, you sign a form and will start the study within several weeks.

What are the benefits of Brain Research Center?

  1. You always come first – everything we do revolves around you.
  2. Experienced team of doctors, neuropsychologists, and nurses.
  3. Open and homely atmosphere – this will make you feel relaxed and right at home.
  4. Clarity – expert in medicine research which is why you will be well informed during all steps of the process and can always come to us for questions.
  5. Always nearby – 3 locations spread through the Netherlands.

What's in it for me?

  • You may experience benefits from a new treatment.
  • You will be monitored by a specialized team of healthcare professionals. They can give you advice and monitor whether there is a change in your daily functioning.
  • You make a meaningful contribution to a future without Alzheimer’s.
  • You contribute to the advancement of science.

Can I participate?

You can participate when:

  • You have mild to moderate Alzheimer’s disease
  • You are between 50 and 85 years old.
  • You have someone close to you/a caregiver who can accompany you during the visits to the research center and can answer questions about your health and functioning, among other things.

Are you unsure whether you meet these requirements? Then you can always apply. We will then check together whether you are suitable to participate. 

Take action against Alzheimer’s. Sign up to participate.

Latest Dementia trials